Literature DB >> 20709061

Structural implications for K5/K12-di-acetylated histone H4 recognition by the second bromodomain of BRD2.

Takashi Umehara1, Yoshihiro Nakamura, Masatoshi Wakamori, Keiko Ozato, Shigeyuki Yokoyama, Balasundaram Padmanabhan.   

Abstract

The BET family proteins recognize acetylated chromatin through their two bromodomains, acting as transcriptional activators or tethering viral genomes to the mitotic chromosomes of their host. The structural mechanism for how the N-terminal bromodomain of human BRD2 (BRD2-BD1) deciphers the mono-acetylated status of histone H4 tail was recently reported. Here we show the crystal structure of the second bromodomain of BRD2 (BRD2-BD2) in complex with the di-acetylated histone H4 tail (H4K5ac/K12ac). To our surprise, a single K5ac/K12ac peptide interacts with two BRD2-BD2 molecules simultaneously: the K5ac residue binds to one BRD2-BD2 molecule while the K12ac residue binds to another. These results provide a structural basis for the recognition of two different patterns of the histone acetylation status by a single bromodomain.
Copyright © 2010 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20709061      PMCID: PMC4158924          DOI: 10.1016/j.febslet.2010.08.013

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  29 in total

1.  Structure and function of a human TAFII250 double bromodomain module.

Authors:  R H Jacobson; A G Ladurner; D S King; R Tjian
Journal:  Science       Date:  2000-05-26       Impact factor: 47.728

2.  The language of covalent histone modifications.

Authors:  B D Strahl; C D Allis
Journal:  Nature       Date:  2000-01-06       Impact factor: 49.962

Review 3.  Bromodomain: an acetyl-lysine binding domain.

Authors:  Lei Zeng; Ming Ming Zhou
Journal:  FEBS Lett       Date:  2002-02-20       Impact factor: 4.124

4.  Solution structure and acetyl-lysine binding activity of the GCN5 bromodomain.

Authors:  B P Hudson; M A Martinez-Yamout; H J Dyson; P E Wright
Journal:  J Mol Biol       Date:  2000-12-01       Impact factor: 5.469

5.  Selective recognition of acetylated histones by bromodomain proteins visualized in living cells.

Authors:  Tomohiko Kanno; Yuka Kanno; Richard M Siegel; Moon Kyoo Jang; Michael J Lenardo; Keiko Ozato
Journal:  Mol Cell       Date:  2004-01-16       Impact factor: 17.970

6.  The double bromodomain protein Brd4 binds to acetylated chromatin during interphase and mitosis.

Authors:  Anup Dey; Farideh Chitsaz; Asim Abbasi; Tom Misteli; Keiko Ozato
Journal:  Proc Natl Acad Sci U S A       Date:  2003-07-02       Impact factor: 11.205

7.  Latent nuclear antigen of Kaposi's sarcoma-associated herpesvirus interacts with RING3, a homolog of the Drosophila female sterile homeotic (fsh) gene.

Authors:  G M Platt; G R Simpson; S Mittnacht; T F Schulz
Journal:  J Virol       Date:  1999-12       Impact factor: 5.103

8.  Structure and ligand of a histone acetyltransferase bromodomain.

Authors:  C Dhalluin; J E Carlson; L Zeng; C He; A K Aggarwal; M M Zhou
Journal:  Nature       Date:  1999-06-03       Impact factor: 49.962

9.  The structural basis for the recognition of acetylated histone H4 by the bromodomain of histone acetyltransferase gcn5p.

Authors:  D J Owen; P Ornaghi; J C Yang; N Lowe; P R Evans; P Ballario; D Neuhaus; P Filetici; A A Travers
Journal:  EMBO J       Date:  2000-11-15       Impact factor: 11.598

10.  Structural basis of lysine-acetylated HIV-1 Tat recognition by PCAF bromodomain.

Authors:  Shiraz Mujtaba; Yan He; Lei Zeng; Amjad Farooq; Justin E Carlson; Melanie Ott; Eric Verdin; Ming-Ming Zhou
Journal:  Mol Cell       Date:  2002-03       Impact factor: 17.970

View more
  24 in total

Review 1.  Basic concepts of epigenetics: impact of environmental signals on gene expression.

Authors:  Elizabeth A Mazzio; Karam F A Soliman
Journal:  Epigenetics       Date:  2012-02       Impact factor: 4.528

Review 2.  The bromodomain: from epigenome reader to druggable target.

Authors:  Roberto Sanchez; Jamel Meslamani; Ming-Ming Zhou
Journal:  Biochim Biophys Acta       Date:  2014-03-28

3.  Structural basis and specificity of acetylated transcription factor GATA1 recognition by BET family bromodomain protein Brd3.

Authors:  Roland Gamsjaeger; Sarah R Webb; Janine M Lamonica; Andrew Billin; Gerd A Blobel; Joel P Mackay
Journal:  Mol Cell Biol       Date:  2011-05-09       Impact factor: 4.272

Review 4.  Bromodomain and extra-terminal (BET) family proteins: New therapeutic targets in major diseases.

Authors:  Balasundaram Padmanabhan; Shruti Mathur; Ramu Manjula; Shailesh Tripathi
Journal:  J Biosci       Date:  2016-06       Impact factor: 1.826

5.  Exploiting a water network to achieve enthalpy-driven, bromodomain-selective BET inhibitors.

Authors:  William R Shadrick; Peter J Slavish; Sergio C Chai; Brett Waddell; Michele Connelly; Jonathan A Low; Cynthia Tallant; Brandon M Young; Nagakumar Bharatham; Stefan Knapp; Vincent A Boyd; Marie Morfouace; Martine F Roussel; Taosheng Chen; Richard E Lee; R Kiplin Guy; Anang A Shelat; Philip M Potter
Journal:  Bioorg Med Chem       Date:  2017-11-04       Impact factor: 3.641

6.  Structural investigation of a pyrano-1,3-oxazine derivative and the phenanthridinone core moiety against BRD2 bromodomains.

Authors:  Aishwarya H Arole; Prashant Deshmukh; Ashok Sridhar; Balasundaram Padmanabhan
Journal:  Acta Crystallogr F Struct Biol Commun       Date:  2022-02-23       Impact factor: 1.056

7.  Bromo- and extraterminal domain chromatin regulators serve as cofactors for murine leukemia virus integration.

Authors:  Saumya Shree Gupta; Tobias Maetzig; Goedele N Maertens; Azar Sharif; Michael Rothe; Magdalena Weidner-Glunde; Melanie Galla; Axel Schambach; Peter Cherepanov; Thomas F Schulz
Journal:  J Virol       Date:  2013-09-18       Impact factor: 5.103

8.  Comparative structure-function analysis of bromodomain and extraterminal motif (BET) proteins in a gene-complementation system.

Authors:  Michael T Werner; Hongxin Wang; Nicole Hamagami; Sarah C Hsu; Jennifer A Yano; Aaron J Stonestrom; Vivek Behera; Yichen Zhong; Joel P Mackay; Gerd A Blobel
Journal:  J Biol Chem       Date:  2019-12-02       Impact factor: 5.157

Review 9.  BET bromodomains as novel epigenetic targets for brain health and disease.

Authors:  Mandakini B Singh; Gregory C Sartor
Journal:  Neuropharmacology       Date:  2020-09-15       Impact factor: 5.250

10.  Bromodomain-Selective BET Inhibitors Are Potent Antitumor Agents against MYC-Driven Pediatric Cancer.

Authors:  P Jake Slavish; Liying Chi; Mi-Kyung Yun; Lyudmila Tsurkan; Nancy E Martinez; Barbara Jonchere; Sergio C Chai; Michele Connelly; M Brett Waddell; Sourav Das; Geoffrey Neale; Zhenmei Li; William R Shadrick; Rachelle R Olsen; Kevin W Freeman; Jonathan A Low; Jeanine E Price; Brandon M Young; Nagakumar Bharatham; Vincent A Boyd; Jun Yang; Richard E Lee; Marie Morfouace; Martine F Roussel; Taosheng Chen; Daniel Savic; R Kiplin Guy; Stephen W White; Anang A Shelat; Philip M Potter
Journal:  Cancer Res       Date:  2020-07-10       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.